相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
Amy J. Osborne et al.
JOURNAL OF IMMUNOLOGY (2018)
C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report
Jiqiu Wen et al.
BMC NEPHROLOGY (2018)
Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss
Frida C. Mohlin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Fengxiao Bu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Complement component C3-The Swiss Army Knife of innate immunity and host defense
Daniel Ricklin et al.
IMMUNOLOGICAL REVIEWS (2016)
Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease
Cheryl L. Tran et al.
PEDIATRIC NEPHROLOGY (2016)
Eculizumab for Treatment of Rapidly Progressive C3 Glomerulopathy
Moglie Le Quintrec et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach
An S. De Vriese et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome
Nicholas R. Medjeral-Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Defining the Complement Biomarker Profile of C3 Glomerulopathy
Yuzhou Zhang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Treatment of C3 Glomerulopathy with Complement Blockers
Marina Vivarelli et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
Veronique Fremeaux-Bacchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome
Karin Janssen van Doorn et al.
CLINICAL KIDNEY JOURNAL (2013)
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome
Caroline Blanc et al.
JOURNAL OF IMMUNOLOGY (2012)
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais et al.
KIDNEY INTERNATIONAL (2012)
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
Peter F. Zipfel et al.
PLOS GENETICS (2007)
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications
Gregory S. Hageman et al.
ANNALS OF MEDICINE (2006)